1. Home
  2. ELTK vs CTSO Comparison

ELTK vs CTSO Comparison

Compare ELTK & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$9.20

Market Cap

57.3M

Sector

Technology

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.70

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
CTSO
Founded
1970
1997
Country
Israel
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.3M
45.9M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
ELTK
CTSO
Price
$9.20
$0.70
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
5.7K
107.5K
Earning Date
03-10-2026
03-11-2026
Dividend Yield
2.02%
N/A
EPS Growth
N/A
N/A
EPS
0.17
N/A
Revenue
$49,310,000.00
$36,979,520.00
Revenue This Year
$18.60
$7.95
Revenue Next Year
$9.04
$8.80
P/E Ratio
$54.51
N/A
Revenue Growth
2.54
23.89
52 Week Low
$7.65
$0.60
52 Week High
$12.19
$1.61

Technical Indicators

Market Signals
Indicator
ELTK
CTSO
Relative Strength Index (RSI) 54.03 52.02
Support Level $8.64 $0.67
Resistance Level $9.41 $0.74
Average True Range (ATR) 0.24 0.04
MACD 0.11 0.01
Stochastic Oscillator 64.06 71.61

Price Performance

Historical Comparison
ELTK
CTSO

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: